1. Volume 140, Issue 2, Pages 478-487.e1 (February 2011)
Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients With Minimal Hepatic Encephalopathy 
Jasmohan S. Bajaj, Douglas M. Heuman, James B. Wade, Douglas P. Gibson, Kia Saeian, Jacob A. Wegelin, Muhammad Hafeezullah, Debulon E. Bell, Richard K. Sterling, R. Todd Stravitz, Michael Fuchs, Velimir Luketic, Arun J. Sanyal 
Gastroenterology 
Volume 140, Issue 2, Pages e1 (February 2011)
DOI: /j.gastro
Copyright © 2011 AGA Institute Terms and Conditions

2. Figure 1
There was a significant reduction in the percentage of patients who improved their total driving errors (16 of 21 [76%]) in the (A) rifaximin group compared with the (B) placebo group (7 of 21 [33%]; P = .013).
Gastroenterology  , e1DOI: ( /j.gastro )
Copyright © 2011 AGA Institute Terms and Conditions

3. Supplementary Figure 1
CONSORT flow. Rifaximin and driving simulation in MHE.
Gastroenterology  , e1DOI: ( /j.gastro )
Copyright © 2011 AGA Institute Terms and Conditions